XRK-33030-65825
4 vaccinations
2 coded responses
47 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 191 / PA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Moderna
-
2021-01-09
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
-
2021-02-04
Dose 2 — Moderna
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Fever · Headache, Muscle or body aches · Be unable to workAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness · Fatigue or tirednessAdult check-in
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-05-08
- 2021-08-07
-
2021-10-23
Dose 3 — Moderna
-
2021-10-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-10-30
- 2021-11-08
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2022-01-22
- 2022-04-23
-
2022-09-15
Dose 4 — Pfizer-BioNTech
-
2022-09-16
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-27
-
2022-12-17
Survey response — 3 months, dose 4MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 2 bad colds back to backMedDRA releases: 2024-11 · check-in free text available
-
2023-03-16
Survey response — 6 months, dose 4MedDRA: Glucose tolerance impaired, Pharyngitis streptococcal — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Moderna | |
| 2 | 2021-02-04 | Moderna | |
| 3 | 2021-10-23 | Moderna | No |
| 4 | 2022-09-15 | Pfizer-BioNTech | No |
Free text
Release 12 — 3 months, dose 4
Symptoms: 2 bad colds back to back
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Glucose tolerance impaired | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pharyngitis streptococcal | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release